Sign in to view content

Canadian Treat-and-Extend Trial With Ranibizumab in nAMD Patients: CANTREAT 36-Month Extension Results

Peter J. Kertes, MD, FRCS(C)

Video
Published 2020

Related

Imaging Signatures and Cytokine Expression in Diabetic Macular Edema From the IMAGINE Study: Biomarker Exploration for Precision Medicine
Sruthi Arepalli, MD
On Demand Cases, Courses, and Papers
2020
New Data and Insights from Several DRCR.net Protocols
Lee Jampol, MD
Updates from the Field
2017
Pharmacokinetic Profile of the Port Delivery System With Ranibizumab in the Phase 3 Archway Trial
John W. Kitchens, MD
Annual Meeting Talks
2021

Category: AMD-Neovascular

See more